← Back to Search

PTSD Therapy for Healthcare Workers' Stress

N/A

Recruiting

Led By Rebecca Sripada, PhD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months

Awards & highlights

Study Summary

This trial is testing a PTSD therapy to help health system workers cope with stress caused by the pandemic. The therapy will be offered through Employee Assistance Programs to see if it can reduce PTSD symptoms.

Who is the study for?

This trial is for healthcare workers with PTSD symptoms post-COVID-19, who have a PCL-5 score ≥33 and stable psychotropic medication use. Participants must work in a healthcare system with an EAP. Those with active psychosis, high suicide risk, current trauma-focused treatment, non-English speakers, severe cognitive impairment or needing detoxification cannot join.Check my eligibility

What is being tested?

The study compares two treatments for PTSD: standard support from Employee Assistance Programs (EAP Treatment as Usual) versus specialized talk therapy called Prolonged Exposure for Primary Care (PE-PC). The goal is to see if PE-PC can better reduce PTSD symptoms and improve overall functioning.See study design

What are the potential side effects?

While the document doesn't list specific side effects of the interventions being studied, talk therapies like PE-PC may sometimes cause temporary increases in distress due to discussing traumatic events.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5) score

Secondary outcome measures

Change in Burnout based on the Oldenburg Burnout Inventory

Change in Depressive Symptoms based on the Patient Health Questionnaire (PHQ-9)

Change in Job Performance based on the Work Productivity and Activity Impairment Questionnaire (WPAI-GH)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Prolonged Exposure for Primary CareExperimental Treatment1 Intervention

Group II: EAP Treatment as Usual (TAU)Active Control1 Intervention

Employee Assistance Programs standard treatment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Prolonged Exposure for Primary Care (PE-PC)

2019

N/A

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,377,728 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,289 Total Patients Enrolled

Rebecca Sripada, PhDPrincipal InvestigatorUniversity of Michigan

1 Previous Clinical Trials

35 Total Patients Enrolled

Media Library

Prolonged Exposure for Primary Care (PE-PC) Clinical Trial Eligibility Overview. Trial Name: NCT05751473 — N/A

Post-Traumatic Stress Disorder Research Study Groups: Prolonged Exposure for Primary Care, EAP Treatment as Usual (TAU)

Post-Traumatic Stress Disorder Clinical Trial 2023: Prolonged Exposure for Primary Care (PE-PC) Highlights & Side Effects. Trial Name: NCT05751473 — N/A

Prolonged Exposure for Primary Care (PE-PC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05751473 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial implemented in a significant number of medical centers across North America?

"The trial is running at seven distinct sites, including the cities of Ann Arbor, Detroit and East Lansing. To reduce your burden when taking part in this study it may be wise to select a medical centre near you."

Answered by AI

Is there any current opportunity to join this research experiment?

"Clinicaltrials.gov data indicates that this clinical trial, which was initially made available on March 1st 2023 and last updated on February 20th 2023, is not presently seeking for enrollees. However, there are 399 other trials actively recruiting participants currently."

Answered by AI

Who else is applying?

What site did they apply to?

Sharp Healthcare

Michigan State University

What portion of applicants met pre-screening criteria?

Met criteria

Why did patients apply to this trial?

I have struggled with PTSD for years and have tried everything including other trials. It affects my daily life and am just hoping for some relief.

PatientReceived 1 prior treatment

I have tried therapy and medication since I was 8 years old. I work in the mental health field, so I know many tricks therapist try to teach. Medication has never worked.

PatientReceived no prior treatments

Recent research and studies

clinicaltrials.govStudy

Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in Frontline Health Care Workers

Rebecca Sripada 2023. "Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in Frontline Health Care Workers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05751473.

All > Ptsd Cincinnati